Abstract:Non-alcoholic fatty liver disease (NAFLD) is affecting up to one-third of the general population in western countries. While the major cause of NAFLD is related to an unhealthy lifestyle, recent evidence has shown a role of chemical exposure in the induction and progression of NAFLD. Perfluorooctanoate (PFOA) is a ubiquitous environmental contaminant that exerts its hepatotoxicity mainly through the activation of peroxisome proliferator-activated receptor α (PPARα). We examined how PFOA might affect the progression of NAFLD and whether a preexisting fatty liver intensified or alleviated the effects of PFOA in the livers. As such, male C57BL/6 mice were fed with a low-fat control diet (CD) or a high fat diet (HFD) for 16 weeks to model normal or steatotic livers, respectively. Mice were then administered with PFOA (1mg/kg/d) by oral gavage for an additional 2, 8, and 16 weeks. Dietary treatment was continued throughout the whole study. We found HFD induced hepatic steatosis, lobular inflammation, and progressive fibrosis in mice. As expected, PFOA activated PPARα, constitutive androstane receptor (CAR) and pregnane X receptor (PXR), regardless of the diet. Gene expression analysis showed the interactions between HFD and PFOA on hepatic nuclear receptors were time-dependent. Hepatocytes growth as measured by DNA synthesis and cell growth genes induced by PFOA were exacerbated in the HFD group after 2 weeks, along with the enhanced activation of PPARα. In contrast, PFOA decreased the severity of hepatic steatosis. In HFD-fed mice, the hepatic triglyceride levels were reduced to 75%, 47%, and 40%, after 2, 8, and 16 weeks of PFOA treatment, respectively, compared to vehicle controls. Transcriptomic analysis showed the preexisting NAFLD enhanced PFOA related lipid oxidation pathways in mice. HFD induced hepatic fibrosis as measured by collagen staining and fibrosis gene markers were also attenuated by PFOA. Taken together, this study demonstrated that the preexisting NAFLD might impact on many biological effects induced by PFOA and thus need to be carefully considered as a factor in risk assessment.

High Fat Diet Feeding Exaggerates Perfluorooctanoic Acid-Induced Liver Injury in Mice via Modulating Multiple Metabolic Pathways

The effects of perfluorooctanoate on high fat diet induced non-alcoholic fatty liver disease in mice.

Involvement of Oxidative Stress and Inflammation in Liver Injury Caused by Perfluorooctanoic Acid Exposure in Mice

Effect of Acute Exposure to PFOA on Mouse Liver Cells in Vivo and in Vitro

Specific Accumulation of Lipid Droplets in Hepatocyte Nuclei of PFOA-exposed BALB/c Mice

The mechanism of immunosuppression by perfluorooctanoic acid in BALB/c mice

Molecular Mechanisms of Perfluorooctanoate-Induced Hepatocyte Apoptosis in Mice Using Proteomic Techniques.

Gestational High‐fat Diet Impaired Demethylation of Pparα and Induced Obesity of Offspring

Distinct bile acid alterations in response to a single administration of PFOA and PFDA in mice

The Effect of Chronic Exposure to a Low Concentration of Perfluorooctanoic Acid on Cognitive Function and Intestinal Health of Obese Mice Induced by a High-Fat Diet.

High Perfluorooctanoic Acid Exposure Induces Autophagy Blockage and Disturbs Intracellular Vesicle Fusion in the Liver

Perfluorooctanoic acid-induced liver injury is potentially associated with gut microbiota dysbiosis

Ability of high fat diet to induce liver pathology correlates with the level of linoleic acid and Vitamin E in the diet

Maternal exposure to perfluorooctanoic acid (PFOA) causes liver toxicity through PPAR-α pathway and lowered histone acetylation in female offspring mice

Chronic exposure to PFO4DA and PFO5DoDA, two perfluoroalkyl ether carboxylic acids (PFECAs), suppresses hepatic stress signals and disturbs glucose and lipid metabolism in male mice.

Perfluorooctanoic Acid Exposure for 28 Days Affects Glucose Homeostasis and Induces Insulin Hypersensitivity in Mice

Combined Exposure to PM2.5 and High-Fat Diet Facilitates the Hepatic Lipid Metabolism Disorders Via ROS/miR-155/PPARγ Pathway.

Environmental exposure to low-dose perfluorohexanesulfonate promotes obesity and non-alcoholic fatty liver disease in mice fed a high-fat diet

HNF4A as a potential target of PFOA and PFOS leading to hepatic steatosis: Integrated molecular docking, molecular dynamic and transcriptomic analyses

Hepatotoxicity of Perfluorooctanoic Acid and Two Emerging Alternatives Based on a 3D Spheroid Model.

Lipid homeostasis and oxidative stress in the liver of male rats exposed to perfluorododecanoic acid.